Medicine & Healthcare Infectious disease

News

24 Mar 2021
Study shows that antibody longevity varies widely from 40 days to as long as several decades and not everyone who has recovered from COVID-19 is immune from reinfection. Individuals with low levels of neutralising antibodies may still be protected if they have robust T-cell immunity. Blood tests and a computer algorithm suggest annual vaccinations might be needed for some individuals to prevent future outbreaks of COVID-19.
Hokkaido University
19 Mar 2021
On March 19, 2021, Hokkaido University, Robotic Biology Institute Inc., iLAC Co., Ltd., and Shionogi & Co., Ltd. have entered into a memorandum of understanding (MOU) toward the establishment of an automated system for the analysis of the novel coronavirus (SARS-CoV-2) in wastewater.
The Northern Pintail, a migratory duck
11 Mar 2021
Scientists have discovered a route of introduction for High Pathogenicity Avian Influenza Virus (HPAIV) H5N8 into Japan and, in parallel, have investigated the potential of two human anti-influenza drugs for the control of HPAI in birds.
Hirofumi Sawa, MD, Ph.D.
04 Mar 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
Chie Nakajima, DVM, Ph.D. and Kyoko Hayashida, DVM, Ph.D.
25 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
Akihiko Sato, DVM, Ph.D.
18 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
16 Feb 2021
The 2nd Call for Proposal for the Small Grant Program "Staying Resilient Amid the Pandemic in Southeast Asia" is now open!
Yoshihiro Sakoda, DVM, Ph.D.
12 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
Hiroshi Kida, DVM, Ph.D
04 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
23 Nov 2020
Taskforce will look into COVID-19 origins, leveraging expertise in One Health, outbreak investigation, virology, lab biosecurity and disease ecology.
26 Oct 2020
Study confirms bats adopt multiple strategies to reduce pro-inflammatory responses, thus mitigating potential immune-mediated tissue damage and disease. Findings provide important insights for medical research on human diseases.
21 Oct 2020
Although most people are likely to accept a future vaccine against COVID-19 if one is proven safe and efficacious, the hesitancy of those who refuse vaccination could stall global efforts to achieve community immunity, suggests a study published in Nature Medicine.
HORIZON
16 Oct 2020
Published: 15 Oct 2020 Institution: Horizon Journals Contact details: Prof. Nayan Kanwal 6121 W.J. Voaz Road, Fort Worth, TX 76169, Texas. USA [email protected] +1(209) 302 9591 News topics: Covid-19 Economic Effect Education Health History People Academic discipline: Social sciences Content type: Announcement Website: https://horizon-jhssr.com/index.php Horizon Oct. 2020 Issue
28 Sep 2020
Testing self-collected saliva samples could offer an easy and effective mass testing approach for detecting asymptomatic COVID-19.
Hokkaido University
24 Sep 2020
A comprehensive search of genetic variation databases has revealed no significant differences across populations and ethnic groups in seven genes associated with viral entry of SARS-CoV-2.
The Programme team is led by HKBU’s eminent scientists and health professionals: (from the left) Professor Jia Wei, Chair Professor in Chinese Medicine and Systems Biology of the School of Chinese Medicine; Professor Guo Yike, Vice-President (Research and Development) and Professor of the Department of Computer Science; Professor Julien Baker, Head and Professor of the Department of Sport, Physical Education and Health; and Professor Bian Zhaoxiang, Director and Chair Professor of the Clinical Division of t
23 Sep 2020
Hong Kong Baptist University (HKBU) has launched a unique Hong Kong Rehabilitation Programme for COVID-19 which aims to deliver comprehensive recovery care to discharged COVID-19 patients by integrating cardiorespiratory and resistance exercise training with the use of Chinese herbal medicine.
21 Sep 2020
Researchers offer first proof that Ultraviolet C light with a 222 nm wavelength -- which is safer to use around humans -- effectively kills the SARS-CoV-2 virus.
21 Sep 2020
Hong Kong Baptist University (HKBU) held the online international symposium “COVID-19 and Beyond, Culturally Speaking” on 15 and 16 September, and over 1300 participants from all over the world gathered to examine and reflect on the COVID-19 pandemic from a cultural perspective.
Macrophage Activation Syndrome in COVID-19
08 Sep 2020
Scientists review macrophage activation syndrome — a feature of the cytokine storm that kills patients with severe cases of COVID-19, as well as possible treatments.
28 Aug 2020
Scientists have reviewed reported cases and testing data of COVID-19 and have determined that changes in the testing rate may be masking the true growth rate and extent of the pandemic.
26 Aug 2020
A group of scientists have detected genetic material from SARS-CoV-2 in untreated wastewater samples collected in April 2020 from two wastewater treatment plants in Louisiana, USA.
Methods used to recover MHV in this study
12 Aug 2020
A group of researchers have demonstrated that, from seven methods commonly used to test for viruses in untreated wastewater, an adsorption-extraction technique can most efficiently detect SARS-CoV-2. This gives us another tool to detect the presence and spread of the COVID-19 pandemic
27 Jul 2020
The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection.
23 Jul 2020
A simple, rapid assay­­ to evaluate neutralizing antibodies that target the SARS-CoV-2 spike protein receptor binding domain (RBD) is described in a paper published in Nature Biotechnology.
22 Jul 2020
– Human dosing of LUNAR-COV19 expected soon. – Differentiated STARR™ mRNA vaccine expected to produce humoral and cellular immunity at very low doses. – New preclinical data demonstrates neutralising antibody titres continue to increase for 50 days after a single administration.
16 Jul 2020
Filipino youth organization, UN SDSN Youth – Philippines, is paving the way for accessible information on the current pandemic.
19 Jun 2020
Have you ever thought about why some people are more vulnerable to catching a virus? And why some get more severe infection than others? Gut microbiota, which is a fine balance between good and bad bacteria, regulates our immune system. Imbalance in gut microbiota (dysbiosis) will make us susceptible to infections.
cPass™
15 May 2020
As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficacy of different vaccine candidates.
30 Apr 2020
A study presenting evidence for the presence of SARS-CoV-2 RNA in the air is published in Nature.
30 Apr 2020
The UK today confirmed that it will be the largest supporter of the international alliance to vaccinate children against deadly diseases, saving millions of lives.

Events

23 Nov 2020 to 24 Nov 2020
Global health emergencies look set to be a part of our lives. What awaits us in 2021 and what lessons can we draw from COVID-19 coverage? How can we support newsrooms and journalists for more informed and impactful journalism about global scientific, technical and human challenges? What role does journalism play in seeking solutions for a better world that is both healthy, and sustainable?

Researchers

Professor Linfa Wang is a Professor with the Emerging Infectious Diseases Programme at Duke-NUS Medical School, Singapore.
Associate Professor Sophia Archuleta is the Head and Senior Consultant of the Division of Infectious Diseases at the National University Hospital, Singapore.
Ashley St. John
Prof. Ashley St. John is an expert in viral immunology and emerging infectious diseases, such as dengue and Zika viruses. She heads the Laboratory of Immunity and Immune Pathology at Duke-NUS Medical School.